Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
6.21
+0.14 (2.31%)
At close: Jan 30, 2025, 4:00 PM
6.22
+0.01 (0.16%)
Pre-market: Jan 31, 2025, 7:23 AM EST
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of $1.89 billion as of January 31, 2025. Its market cap has decreased by -11.64% in one year.
Market Cap
1.89B
Enterprise Value
1.57B
1-Year Change
-11.64%
Ranking
Category
Stock Price
$6.21
Market Cap Chart
Since October 15, 2010, Iovance Biotherapeutics's market cap has increased from $79.00M to $1.89B, an increase of 2,295.81%. That is a compound annual growth rate of 24.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2025 | 1.89B | -16.08% |
| Dec 31, 2024 | 2.26B | 8.40% |
| Dec 29, 2023 | 2.08B | 106.29% |
| Dec 30, 2022 | 1.01B | -66.33% |
| Dec 31, 2021 | 3.00B | -55.99% |
| Dec 31, 2020 | 6.81B | 94.85% |
| Dec 31, 2019 | 3.49B | 220.44% |
| Dec 31, 2018 | 1.09B | 87.59% |
| Dec 29, 2017 | 581.10M | 34.67% |
| Dec 30, 2016 | 431.50M | 16.84% |
| Dec 31, 2015 | 369.30M | 69.79% |
| Dec 31, 2014 | 217.50M | 9.63% |
| Dec 31, 2013 | 198.40M | 1,053.49% |
| Dec 31, 2012 | 17.20M | -78.23% |
| Dec 30, 2011 | 79.00M | 5.05% |
| Dec 31, 2010 | 75.20M | -4.81% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.26B |
| UnitedHealth Group | 502.08B |
| Novo Nordisk | 374.46B |
| Johnson & Johnson | 368.05B |
| AbbVie | 310.40B |
| Merck & Co. | 250.31B |
| Thermo Fisher Scientific | 232.08B |
| Abbott Laboratories | 223.42B |